Evidence map›Paper›PMID 28099628›Full record

ArticleRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)

Elevated plasma concentrations of S100 calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders.

Selin Aktan Guloksuz, Osman Abali, Esin Aktas Cetin, Sema Bilgic Gazioglu, Gunnur Deniz, Abdurrahman Yildirim, Ivana Kawikova, Sinan Guloksuz, James F Leckman

Open access · diamondAbstract read
In one paragraph

Article in Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?International journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Selin Aktan GuloksuzChild Study Center, School of Medicine, Yale University, New Haven, CT, USA.
Osman AbaliDepartment of Child and Adolescent Psychiatry, Istanbul University School of Medicine, Istanbul, Turkey.
Esin Aktas CetinDepartment of Immunology, Institute of Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey.
Sema Bilgic GaziogluDepartment of Immunology, Institute of Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey.
Gunnur DenizDepartment of Immunology, Institute of Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey.
Abdurrahman YildirimDepartment of Pediatrics, Istanbul Memorial Hospital, Istanbul, Turkey.
Ivana KawikovaDepartment of Pediatrics, School of Medicine, Yale University, New Haven, CT, USA.
Sinan GuloksuzDepartment of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.
James F LeckmanChild Study Center, School of Medicine, Yale University, New Haven, CT, USA.
Istanbul University · TRMaastricht University · NLYale University · USIstanbul Memorial Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objective: To investigate plasma concentrations of S100B (a calcium-binding protein derived primarily from the glia) and inflammatory cytokines in children with autism and the relationship between S100B and cytokine concentrations.

methods: Plasma levels of S100B, tumor necrosis factor alpha (TNF-α), interferon gamma, interleukin (IL)-1β, IL-4, IL-6, IL-10, and IL-17A were measured in 40 unmedicated children with autism and 35 normally developing healthy children. The severity of autism was assessed using the Childhood Autism Rating Scale (CARS).

results: Concentrations of both S100B and TNF-α were higher in children with autism before and after adjusting for a priori-selected confounders (age, sex, and body mass index). S100B concentrations were higher in children with severe autism compared to children with mild-moderate autism. However, this association remained as a trend after adjusting for confounders. S100B concentrations correlated positively with TNF-α concentrations.

conclusion: Our findings showing an increase in peripheral concentrations of S100B and TNF-α provide limited support to the hypothesis about the roles of altered immune function and S100B in autism spectrum disorder (ASD). Studies of larger numbers of well-characterized individuals with ASD are needed to clarify the potential role of the immune system in the pathophysiology of this disorder.

Indexed as

Autism Spectrum DisorderBiomarkersBody Mass IndexChildChild, PreschoolCross-Sectional StudiesFemaleHumansInterleukinsMaleS100 Calcium Binding Protein beta SubunitSeverity of Illness IndexTumor Necrosis Factor-alphaBiomarkersInterleukinsS100B protein, humanS100 Calcium Binding Protein beta SubunitTumor Necrosis Factor-alpha

Identifiers

PMID28099628
PMCPMC7111377
OpenAlexW2574487650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.